PAK4 and hepatocellular carcinoma: miRNA‐34a promotes tumor metastasis in HBV‐positive HCC patients [7]; decreased miR‐199a/b‐3p in HCC suppresses HCC growth by inhibiting PAK4/Raf/MEK/ERK signaling pathway [8].